Ensign Peak Advisors, Inc Legend Biotech Corp Transaction History
Ensign Peak Advisors, Inc
- $51.2 Billion
- Q1 2025
A detailed history of Ensign Peak Advisors, Inc transactions in Legend Biotech Corp stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 9,050 shares of LEGN stock, worth $290,143. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,050
Previous 7,850
15.29%
Holding current value
$290,143
Previous $255,000
20.39%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding LEGN
# of Institutions
237Shares Held
60MCall Options Held
591KPut Options Held
381K-
Westfield Capital Management CO LP Boston, MA6.92MShares$222 Million1.21% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$192 Million8.76% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$183 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.77MShares$121 Million4.61% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.96MShares$95 Million2.42% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.37B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...